Skip to main content
logo
Astellas Pharma Inc. (ALPMY)
OTCMKTS · Delayed Price · Currency is USD
9.69
-0.04 (-0.41%)
Jul 18, 2025, 4:00 PM EDT

Revenue by Product

Fiscal year is April - March.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 2016 - 2018
Pharmaceutical
1,603.67B
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Growth
5.60%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is April - March.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 2016 - 2018
United States
663.11B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
1.63%
Log In
Log In
Log In
Log In
Upgrade
Established Markets
415.57B
Log In
Log In
Log In
Log In
Upgrade
Established Markets Growth
15.95%
Log In
Log In
Log In
Log In
Upgrade
Japan
270.13B
Log In
Log In
Log In
Log In
Upgrade
Japan Growth
2.98%
Log In
Log In
Log In
Log In
Upgrade
International
159.07B
Log In
Log In
Log In
Log In
Upgrade
International Growth
9.91%
Log In
Log In
Log In
Log In
Upgrade
Greater China
88.50B
Log In
Log In
Log In
Log In
Upgrade
Greater China Growth
10.61%
Log In
Log In
Log In
Log In
Upgrade
Other
7.30B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-64.80%
Log In
Log In
Log In
Log In
Upgrade